Search results for "renal insufficiency"

showing 10 items of 175 documents

The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.

2013

Background. Growing evidence indicates that vitamin D receptor activation may have antiproteinuric effects. We aimed to evaluate whether vitamin D supplementation with daily cholecalciferol could reduce albuminuria in proteinuric chronic kidney disease (CKD) patients. Methods. This 6-month prospective, controlled, intervention study enrolled 101 non-dialysis CKD patients with albuminuria. Patients with low 25(OH) vitamin D [25(OH)D] and high parathyroid hormone (PTH) levels (n = 50; 49%) received oral cholecalciferol (666 IU/day), whereas those without hyperparathyroidism (n = 51; 51%), independent of their vitamin D status, did not receive any cholecalciferol, and were considered as the co…

AdultMalemedicine.medical_specialtyUrologyRenal functionParathyroid hormoneAdministration OralCalcitriol receptorPhosphateschemistry.chemical_compoundYoung AdultChronic kidney diseaseEstadística e Investigación OperativaInternal medicinemedicineVitamin D and neurologyAlbuminuriaHumansProspective StudiesRenal Insufficiency ChronicVitamin DAgedCholecalciferolAged 80 and overTransplantationHyperparathyroidismbusiness.industryHyperparathyroidismVitaminsMiddle Agedmedicine.diseaseVitamin D DeficiencyEndocrinologychemistryNephrologyParathyroid HormoneDietary SupplementsAlbuminuriaDisease ProgressionFemalemedicine.symptomCholecalciferolbusinessKidney diseaseNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD

2013

BackgroundMany authors have investigated the numerous connections between the nervous system and kidneys, and recent literature has indicated that these similar systems are interconnected. Recent scientific works have shown that there is similarity between the cerebral cortex 'viscera representation' and the 'motor omunculus'. We studied the connection between the brain and kidney in vivo using repetitive transcranial magnetic stimulation (rTMS). Proteinuria and albuminuria were used as markers of renal response in patients with diabetes (DP) and in a group of healthy subjects (HSs) who received rTMS for 5 consecutive days.MethodsThe study population consists of the following four groups: G…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentUrologyRenal functionStimulationKidneyGlomerular filtration barrierYoung AdultInternal medicineDiabetes mellitusDiabetes MellitusmedicineAlbuminuriaHumansRenal Insufficiency ChronicSettore MED/14 - NefrologiaTransplantationKidneyProteinuriaSettore MED/27 - Neurochirurgiabusiness.industryMedicine (all)BrainDiabetes MellituMiddle Agedmedicine.diseaseHealthy VolunteerTranscranial Magnetic StimulationHealthy VolunteersTranscranial magnetic stimulationProteinuriaTreatment Outcomemedicine.anatomical_structureEndocrinologyBrain stimulationNephrologyCase-Control StudiesBrain stimulationAlbuminuriaFemalemedicine.symptomCase-Control StudiebusinessHuman
researchProduct

Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort

2021

Abstract Aims To estimate the attributable risk of renal function on all-cause mortality and cardiovascular hospitalization in patients with diabetes. Methods A prospective cohort study in 19,469 adults with diabetes, free of cardiovascular disease, attending primary care in Spain (2008–2011). The estimated glomerular filtration rate (eGFR) and other variables were collected and patients were followed to the first hospitalization for coronary or stroke event, or death, until the end of 2012. The cumulative incidence of the study endpoints by eGFR categories was graphically displayed and adjusted population attributable risks (PARs) for low eGFR was calculated. Results Mean follow-up was 3.2…

Adultmedicine.medical_specialtyhypertensionkidney dysfunctionEndocrinology Diabetes and MetabolismPopulationRenal function030209 endocrinology & metabolismKidneyCohort Studies03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineDiabetes mellitusattributable riskDiabetes MellitusInternal MedicinemedicineHumansCumulative incidenceProspective StudiesRegistries030212 general & internal medicineRenal Insufficiency ChronicProspective cohort studyeducationStrokeeducation.field_of_studyNutrition and Dieteticsbusiness.industrymedicine.diseasemortalitycardiovascular diseasesHospitalizationCardiovascular Diseasesdiabetes mellitusAttributable riskCohortFamily PracticebusinessGlomerular Filtration RatePrimary Care Diabetes
researchProduct

Glycated albumin as a glycaemic marker in patients with advanced chronic kidney disease and anaemia: a preliminary report.

2019

BACKGROUND: The association between glycated albumin (GA) and glycaemic status has not been fully described in patients with advanced chronic kidney disease (CKD) in relation to anaemia. The aim of this study was to evaluate the relationship between GA and fasting plasma glucose (FPG) and HbA1c in patients with advanced CKD and to evaluate the influence of anaemia in such relationship. MATERIALS AND METHODS: Patients with CKD stage 4 or 5 were included in the study. eGFR was calculated by the CKD-EPI creatinine equation. Plasma GA was measured by an enzymatic method. RESULTS: Eighty-one patients were included in the study, 46 (57%) were males; the mean age was 67 ± 14 years. HbA1c was corre…

Blood GlucoseGlycation End Products AdvancedMalemedicine.medical_specialtyClinical Biochemistry030209 endocrinology & metabolism030204 cardiovascular system & hematologyGastroenterologyrenal insufficiency03 medical and health sciences0302 clinical medicineGlycated albuminPreliminary reportInternal medicinemedicineHumansIn patientGlycated Serum AlbuminRenal Insufficiency ChronicSerum AlbuminAgedGlycated Hemoglobinanaemiabusiness.industryAnemiaGeneral MedicineFastingmedicine.diseaseglycated haemoglobin ARegression AnalysisFemalebusinessBiomarkersKidney diseaseScandinavian journal of clinical and laboratory investigation
researchProduct

Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month re…

2018

OBJECTIVE Dual-release hydrocortisone (DR-HC) provides physiological cortisol exposure, leading to an improvement of anthropometric and metabolic parameters. The aim of the study was to evaluate the effects of DR-HC on insulin secretion and sensitivity and cardiometabolic risk, indirectly expressed by the visceral adiposity index (VAI). DESIGN AND PATIENTS Retrospective analysis of 49 patients, 13 with primary and 36 with secondary adrenal insufficiency (AI), respectively, on conventional glucocorticoid treatment at baseline and switched to DR-HC for 36 months. Overall, 24 patients had AI-pre-diabetes (impaired fasting glucose, impaired glucose tolerance and the combination), and 25 had AI-…

Blood Glucoseinsulin secretionmedicine.medical_specialtyWaistHydrocortisoneEndocrinology Diabetes and Metabolism030209 endocrinology & metabolism030204 cardiovascular system & hematologySettore MED/13 - EndocrinologiaImpaired glucose tolerancePrediabetic State03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusGlucose IntolerancemedicineAdrenal insufficiencyHumansplenadrenPrediabetesGlucocorticoidsHydrocortisoneRetrospective Studiesbusiness.industryAdrenal insufficiency; diabetes; dual-release hydrocortisone; insulin secretion; plenadren; Endocrinology Diabetes and MetabolismFastingImpaired fasting glucosemedicine.diseaseEndocrinologydiabetedual-release hydrocortisoneInsulin ResistanceWaist CircumferencebusinessGlucocorticoidmedicine.drugAdrenal InsufficiencyClinical endocrinology
researchProduct

Irisinemia: A Novel Concept to Coin in Clinical Medicine?

2013

Skeletal muscle can express and release substances such as cytokines or other peptides capable of modulating metabolic processes. These cytokines, named ‘myokines', function as hormones either locally within the muscle or by targeting distant organs. A novel peptidic myokine named ‘irisin' has been recently identified. It has been noted that circulating irisin levels are lower in type 2 diabetes (T2D) compared with nondiabetic controls as well as in patients with chronic kidney disease. In addition, a negative correlation between the hemoglobin A1c (HbA1c) and circulating levels of irisin has been also observed. Thus, the blood concentration of irisin may reflect the metabolic status of pat…

Blood Glucosemedicine.medical_specialtyendocrine system diseasesMedicine (miscellaneous)Type 2 diabetesMetabolic DiseasesDiabetes mellitusInternal medicineMyokineHumansMedicineObesityRenal Insufficiency ChronicMuscle SkeletalNutrition and Dieteticsbusiness.industrynutritional and metabolic diseasesSkeletal musclemedicine.diseaseObesityFibronectinsMetabolism disorderEndocrinologymedicine.anatomical_structureDiabetes Mellitus Type 2ImmunologyCytokinesbusinessHormoneKidney diseaseAnnals of Nutrition and Metabolism
researchProduct

Haemostasis in chronic kidney disease

2013

The coagulation system has gained much interest again as new anticoagulatory substances have been introduced into clinical practice. Especially patients with renal failure are likely candidates for such a therapy as they often experience significant comorbidity including cardiovascular diseases that require anticoagulation. Patients with renal failure on new anticoagulants have experienced excessive bleeding which can be related to a changed pharmacokinetic profile of the compounds. However, the coagulation system itself, even without any interference with coagulation modifying drugs, is already profoundly changed during renal failure. Coagulation disorders with either episodes of severe bl…

Blood PlateletsExcessive Bleedingmedicine.medical_specialtymedicine.medical_treatmentHemorrhageThrombophiliaInternal medicinemedicineHumansRenal InsufficiencyRenal Insufficiency ChronicHemostatic functionBlood CoagulationCoagulation DisorderHemostasisTransplantationbusiness.industryAnticoagulantsThrombosisBlood Coagulation Disordersmedicine.diseaseThrombosisSurgeryOxidative StressCoagulationNephrologyAntibodies AntiphospholipidCardiologyEndothelium VascularHemodialysisbusinessKidney diseaseNephrology Dialysis Transplantation
researchProduct

Management of secondary hyperparathyroidism in uremic patients : the role of the new vitamin D analogs

2007

Secondary hyperparathyroidism - a common comorbid condition in patients with chronic renal insufficiency - is considered a consequence of critical determinants such as hypocalcemia, phosphate retention and reduced levels of calcitriol production. In this complex mechanism, the skeletal apparatus and the nonskeletal targets such as vascular and heart valves are often involved, thus explaining the increased risk of cardiovascular morbidity and mortality of uremic patients. In this review we will focus on the major role played by Calcitriol deficiency as a trigger of secondary hyperparathyroidism and the crucial need for obiquitous vitamin D receptor activation in order to have an optimal PTH …

Bone Density Conservation AgentsCalcitriolHypocalcemiaErgocalciferolsHumansReceptors CalcitriolHyperparathyroidism SecondaryRenal Insufficiency ChronicVitamin DVitamin D DeficiencyPhosphatesUremia
researchProduct

Relationship Between Carotid Atherosclerosis and Pulse Pressure with Renal Hemodynamics in Hypertensive Patients.

2015

BACKGROUND Structural atherosclerotic damage, arterial stiffness, pulse pressure (PP), and renal hemodynamics may interact and influence each other. Renal resistance index (RRI) appears as a good indicator of systemic vascular changes. The aim of our study was to assess the independent relationships of carotid intima-media thickness (cIMT), aortic pulse wave velocity (aPWV), and peripheral PP with RRI in hypertensives with various degrees of renal function. METHODS We enrolled 463 hypertensive patients (30-70 years) with normal renal function (group 0; n = 280) and with chronic kidney disease (groups I-V; n = 183). All subjects underwent ultrasonographic examination of intrarenal and caroti…

Carotid Artery DiseasesMaleSettore MED/09 - Medicina InternaHemodynamicsBlood Pressure030204 cardiovascular system & hematologyKidneyCarotid Intima-Media Thicknessrenal resistance index.0302 clinical medicineatherosclerosiarterial stiffne030212 general & internal medicineUltrasonography Doppler ColorPulse wave velocityBlood Pressure Monitoring AmbulatoryMiddle AgedPulse pressuremedicine.anatomical_structureHypertensionCardiologyFemaleOriginal ArticleAdultmedicine.medical_specialtyAmbulatory blood pressurerenal hemodynamicPulse Wave AnalysisRenal Circulation03 medical and health sciencesVascular StiffnessInternal medicineInternal MedicinemedicineHumansRenal Insufficiency ChronicAgedSettore MED/14 - Nefrologiabusiness.industrypulse pressuremedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareSurgeryBlood pressureCross-Sectional StudiesArterial stiffnessVascular resistanceVascular Resistancebusinesschronic kidney diseaseKidney diseaseAmerican journal of hypertension
researchProduct

Renal haemodynamics and severity of carotid atherosclerosis in hypertensive patients with and without impaired renal function.

2014

Background and Aim. Renal resistance index (RRI), assessed by Duplex-Doppler sonography, has been classically considered as a mere expression of intrarenal vascular resistance. Recent studies, however, have showed that RRI is also influenced by upstream factors, especially arterial compliance, confirming its possible role as a marker of systemic vascular alterations. Several studies have shown that carotid intima-media thickness (cIMT) and carotid plaques (cP), assessed by ultrasonography, are documented markers of subclinical organ damage as well as expression of progressive atherosclerotic disease, and that they get worse with the progressive deterioration of renal function. The study was…

Carotid atherosclerosisAdultCarotid Artery DiseasesMalemedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Renal functionBlood PressureKidneyCarotid Intima-Media ThicknessBody Mass IndexImpaired renal functionRisk FactorsInternal medicinemedicineHumansRenal InsufficiencyStage (cooking)TriglyceridesSubclinical infectionAgedSettore MED/14 - NefrologiaNutrition and Dieteticsbusiness.industryCholesterol HDLHemodynamicsCholesterol LDLMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolareCompliance (physiology)Atherosclerosis.medicine.anatomical_structureCross-Sectional StudiesCreatinineHypertensioncardiovascular systemCardiologyVascular resistancePopulation studyFemaleSettore MED/36 - Diagnostica Per Immagini E RadioterapiaCardiology and Cardiovascular MedicinebusinessBiomarkersNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct